Champions Oncology, Inc. lost $0.08 per diluted share in fiscal year 2026. This represents a decrease of 124.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Champions Oncology, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Champions Oncology, Inc.'s diluted earnings per share in fiscal year 2026?
Champions Oncology, Inc. lost $0.08 per diluted share in fiscal year 2026.
How fast is Champions Oncology, Inc.'s diluted earnings per share growing?
Champions Oncology, Inc. (CSBR) diluted earnings per share fell by 124.2% year over year, from $0.33 to -$0.08 in fiscal year 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Champions Oncology, Inc. (CSBR) reported on that line in every period on record.
